This article examines the complex power dynamics inherent in interdisciplinary biomimetic collaborations between biologists, engineers, chemists, and clinicians.
This article critically examines the pervasive naturalistic fallacy in biomimetic design for pharmaceutical research.
This article provides a comprehensive analysis of nanoparticle-induced complement activation (NICA), a critical barrier in nanomedicine development.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on overcoming nanoparticle stability and shelf-life challenges.
This article provides a comprehensive resource for researchers and drug development professionals tackling nanoparticle instability in endolysosomal compartments.
This article provides a detailed scientific and technical analysis of nanoparticle-induced cytotoxicity and immunogenicity, critical challenges in nanomedicine development.
This article provides a systematic guide for researchers, scientists, and drug development professionals on addressing nanoparticle aggregation during storage.
This article provides a comprehensive guide for researchers and drug development professionals on characterizing nanomaterials within complex biological fluids like blood serum, plasma, and interstitial fluid.
This article provides a comprehensive guide for researchers and drug development professionals on the critical challenge of material biocompatibility in organ-on-chip (OOC) technology.
Lysosomal entrapment is a critical barrier limiting the therapeutic efficacy of nanoparticle-mediated drug delivery.